Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Journal of Crohn'S & Colitis|March 3, 2016
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Current Medical Research and Opinion|June 24, 2020
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern ItalyRoberta Roberti, Luigi Francesco Iannone, Caterina Palleria, et al.
Cancers|February 15, 2022
Incident Colorectal Cancer in Inflammatory Bowel DiseaseBenedetto Neri, Maria Lia Scribano, Alessandro Armuzzi, et al.
Inflammatory Bowel Diseases|January 17, 2017
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab BiosimilarGionata Fiorino, Natalia Manetti, Alessandro Armuzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 21, 2013
Adalimumab in active ulcerative colitis: a "real-life" observational study, Alessandro Armuzzi, Livia Biancone, et al.
Inflammatory Bowel Diseases|September 10, 2019
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
The American Journal of Gastroenterology|April 25, 2022
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha InhibitorsSara Onali, Daniela Pugliese, Flavio Andrea Caprioli, et al.
Inflammatory Bowel Diseases|August 24, 2018
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across ItalyAlessandro Armuzzi, Gionata Fiorino, Angela Variola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 31, 2024
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)Gaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.
European Journal of Gastroenterology & Hepatology|October 1, 2019
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' studyAnna Viola, Rita Monterubbianesi, Giuseppe Scalisi, et al.
Pageof 11